Fig. 5: Immune cell density and pathological complete response. | npj Precision Oncology

Fig. 5: Immune cell density and pathological complete response.

From: Immune microenvironment characterisation and dynamics during anti-HER2-based neoadjuvant treatment in HER2-positive breast cancer

Fig. 5

a Odds ratios (95% confidence interval) for pathologic complete response (pCR) for 10% increases in TIL levels and 1000 cells/mm2 increases in immune cell density evaluated on baseline and Day 15 (on-treatment) samples. b Odds ratios (95% confidence interval) for pathologic complete response (pCR) for increases in % of proliferating immune cells for each immune cell subpopulation evaluated on baseline and day 15 (on-treatment) samples. c Odds ratios (95% confidence interval) for pathologic complete response (pCR) for 1000 cells/mm2 increases in immune cell density according to immune cell localisation evaluated on baseline and day 15 (on-treatment) samples.

Back to article page